Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 455.0 and a stoploss at Rs 425 from entry point.

The analyst suggested a stoploss at Rs 435.

Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 450.0 and a stoploss at Rs 433 from entry point.

Jay Thakkar recommended to keep stoploss at Rs 408.

Sell Sun Pharmaceutical Industries Ltd. at a price target of Rs 395.0 and a stoploss at Rs 422 from entry point.

Buy Sun Pharmaceutical Industries at a price target of Rs 655 and a stop loss at Rs 588 from the entry point.

Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 520.0 and a stop loss at Rs 502 from entry point.

Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 640.0 and a stop loss at Rs 550 from entry point.

Sell Sun Pharmaceutical Industries Ltd. at a price target of Rs 543.6 and a stop loss at Rs 559.4 from entry point.

Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 634.0 and a stop loss at Rs 575 from entry point.

Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 610.0 and a stop loss at Rs 565 from entry point.

Buy Sun Pharmaceutical Industries at a price target of Rs 530 and a stop loss at Rs 498 from entry point.

Buy Sun Pharmaceutical Industries at a price target of Rs 585 and a stop loss at Rs 553 from entry point.

Buy Sun Pharmaceutical Industries at a price target of Rs 550 and a stop loss at Rs 520 from entry point.

Sell Sun Pharmaceutical Industries Ltd. at a price target of Rs 519 and a stop loss at Rs 588 from entry point.

The decision to bring back Sundaram from Taro signals a move that's possibly aimed at shaping the next stage of growth for India's largest ...

The virtual liver mimics normal liver functions and generates likely outcomes of new drugs before the drug is tested on animals and humans.